A detailed history of Thompson Davis & Co., Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 1,537 shares of LLY stock, worth $1.21 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
1,537
Previous 1,687 8.89%
Holding current value
$1.21 Million
Previous $1.53 Million 10.87%
% of portfolio
1.03%
Previous 1.36%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $115,821 - $144,003
-150 Reduced 8.89%
1,537 $1.36 Million
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $8,698 - $10,908
12 Added 0.72%
1,687 $1.53 Million
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $23,688 - $31,691
-40 Reduced 2.33%
1,675 $1.3 Million
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $451,663 - $532,451
-860 Reduced 33.4%
1,715 $999,000
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $554,242 - $764,107
-1,275 Reduced 33.12%
2,575 $1.38 Million
Q2 2023

Jul 13, 2023

BUY
$350.74 - $468.98 $17,537 - $23,449
50 Added 1.32%
3,850 $1.81 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $15,531 - $18,241
50 Added 1.33%
3,800 $1.3 Million
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $16,077 - $18,733
50 Added 1.35%
3,750 $1.37 Million
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $177,888 - $202,722
600 Added 19.35%
3,700 $1.2 Million
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $55,746 - $65,454
-200 Reduced 6.06%
3,100 $1.01 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $367,923 - $431,996
1,320 Added 66.67%
3,300 $1.07 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $464,686 - $577,486
1,980 New
1,980 $567,000
Q1 2018

May 02, 2018

SELL
$74.21 - $87.6 $7,420 - $8,760
-100 Closed
0 $0
Q4 2017

Feb 05, 2018

SELL
$81.94 - $87.89 $51,458 - $55,194
-628 Reduced 86.26%
100 $8,000
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $4,470 - $4,961
58 Added 8.66%
728 $62,000
Q2 2017

Aug 10, 2017

BUY
N/A
670
670 $55,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $747B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.